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Abstract Sequence analysis of several cDNAs encoding the
phasin protein of Ralstonia eutropha indicated that the carboxyl
terminus of the resulting derived protein sequence is different
from that reported previously. This was confirmed by: (1)
sequencing of the genomic DNA; (2) SDS-PAGE and peptide
analysis of wild-type and recombinant phasin; and (3) mass
spectrometry of wild-type phasin protein. The results have
implications for the model proposed for the binding of this
protein to polyhydroxyalkanoic acid granules in the bacterium.
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1. Introduction
PHAs are carbon-oxygen storage polyesters occurring as
intracellular granules in many bacteria [1]. The monomer sub-
units of PHA are usually 3-hydroxyalkanoic acids with a
number of di¡erent side groups. The PHA polymers are bio-
degradable thermoplastics with the potential to replace the
non-biodegradable plastics currently manufactured from the
Earth’s hydrocarbon reserves. Poly(3-hydroxybutyrate), the
most studied member of the class, is synthesized from ace-
tyl-CoA in a three-step pathway by the bacterium Ralstonia
eutropha (formerly Alcaligenes eutrophus [2]). The copolymer
poly(3-hydroxybutyrate-co-3-hydroxyvalerate) is produced
commercially via the industrial fermentation of R. eutropha
and is marketed as the biodegradable polythene substitute
BIOPOL by Monsanto Corporation.
PHA granules in R. eutropha are thought to be enveloped in
a predominantly protein monolayer [3]. The most abundant
granule-associated protein is phasin, encoded by the phaP
gene. Phasin appears to serve a structural role in a manner
analogous to that of the oleosin proteins in oleaceous plants
[4], which form a boundary layer sequestering hydrophobic
triglycerides from the cytoplasm. Catalytically active gran-
ule-associated proteins such as the PHA synthase and depol-
ymerase enzymes are also present on the granule surface but
to a lesser extent (representing approximately 10^15% of the
granule surface in one organism [5]). The proteins are not
integral parts of a phospholipid mono- or bilayer and phos-
pholipids cover less than 10% of the granule [4]. PHA biosyn-
thesis in heterologous hosts in the absence of phasin results in
the deposition of a single large granule rather than the numer-
ous small granules seen in the presence of phasin and an
identical phenotype is observed in R. eutropha cells in which
transcription of the phasin gene has been disrupted by a trans-
poson [6]. The rate of PHA biosynthesis in these mutant R.
eutropha cells is lower than that of the wild-type, as is the
speci¢c activity of the PHA synthase enzyme. In vitro experi-
ments in the biosynthesis of PHA show that PHA synthase
turnover is increased in the presence of phasin, although re-
ductions in speci¢c activity or increases in product accumu-
lation were not observed [7]. Western blot analysis of PHA
granule-associated proteins from 50 bacterial strains using
antibodies raised to the phasin of R. eutropha identi¢ed
many PHA-accumulating bacteria which possessed cross-re-
acting proteins, while protein sequencing data from several
Ralstonia strains indicated that phasin is highly conserved
within the genus [8]. All of these observations would suggest
that phasins have an important role in the dynamic processes
of PHA accumulation and utilization.
Very little is known about the secondary and tertiary struc-
tures of the phasin protein in vivo. However, a model has
been proposed for the anchoring of monomeric phasin to a
phospholipid monolayer of a PHA granule, based on common
motifs found in the deduced amino acid sequences of phasins
of R. eutropha and Rhodococcus ruber [6]. These two proteins
are of disparate sizes (reported as 24 kDa and 14 kDa, re-
spectively) but each has been reported to contain two seg-
ments of hydrophobic and amphiphilic amino acids at the
carboxyl terminus. Deletion of these regions (termed HD1
and HD2) from the R. ruber phasin prevented the protein
from binding to PHA granules [9]. HD1 and HD2 are thought
to span the granular membrane and anchor the protein, al-
lowing the phasin to act as an amphiphilic barrier between the
hydrophilic cytoplasm and the hydrophobic PHA granule. A
similar process of granule binding has been assumed to take
place with the R. eutropha phasin as it appeared to contain
similarly non-hydrophilic regions at the carboxyl terminus.
In this article we report three di¡erences in the DNA se-
quence of the R. eutropha phasin cDNA to the published data
with subsequent alterations in the primary structure of the
resulting protein. The result is con¢rmed by direct analysis
of the phasin protein by SDS-PAGE, amino-terminal se-
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quencing and mass spectrometry. These di¡erences are un-
likely to be a consequence of a tRNA mutation. The primary
sequence of the new protein is incompatible with the current
model of phasin anchorage to PHA granules. However the
data in this work have allowed us to formulate an alternative
model.
2. Materials and methods
2.1. Bacterial strains
Wild-type R. eutropha strain H16 (DSM428) was generously do-
nated by Dr. A.J. Anderson (University of Hull, UK). R. eutropha
strain H2275 and the plasmid pVK5000 was made available by Dr. A.
Steinbuºchel (Universitaºt Muºnster, Germany). Freshly harvested
R. eutropha H16 PHA granules were kindly supplied by Dr. H.E.
Valentin and Dr. M. Tran (Monsanto Corporation, USA).
2.2. PCR
PCR was carried out using Vent Polymerase (New England
Biolabs) according to the manufacturer’s recommendations. The
oligomers 5PGA24 (GAAGTTCCATATGGCCATGGTTATGAT-
CCTCACCCC) and 3PGA24 (CAGCACCGCATATGGATCCT-
CAGGGCACTACCTTCATC), designed to amplify the coding re-
gion of the R. eutropha phasin gene (Genbank accession number
X85729) (see Fig. 1), were used to amplify cDNA. The cycle condi-
tions were as follows: hot start; 4 min at 95‡C; 10 cycles of 1 min
plateaux at 95‡C, 45‡C and 72‡C; 25 cycles of 1 min plateaux at 95‡C,
55‡C and 72‡C; 10 min at 72‡C. Templates used were: plasmid
pVK5000 (contains 5 kbp segment of the R. eutropha genome with
a single ORF encoding the phasin protein) [6], R. eutropha strain
H2275 (in which a transposon prevents transcription of the phasin
gene phaP [6]), and R. eutropha strain H16.
2.3. Cloning and overexpression of phasin cDNA
The pCR-script (amp) cloning kit (Stratagene) was used to clone
the 727 bp PCR products from pVK5000 and H2275. The cDNA
derived from pVK5000 was subcloned into pET11a to create the
vector pET-GA24, which was used to transform E. coli strain
BL21(DE3) for overexpression of the phasin gene via IPTG-mediated
induction. Plasmid was prepared for restriction analysis and sequenc-
ing using the Hybaid Recovery Plasmid Mini Prep Kit.
2.4. DNA sequencing
Dideoxy chain termination DNA sequencing was performed using
the primers int1 (CCGGCTGCACGGCTGCGGCC) and int2
(CTCGAAGAACGTGCAAGCGC), and also with primers annealing
to the vectors used. Both strands were sequenced using an ABI 377
Prism DNA Sequencer.
2.5. DNA and protein sequence analysis
Alignments and sequence analysis were performed using the GCG
program suite [10] at the SEQNET service (CCL, Daresbury Labo-
ratory). The Protein Structure Analysis Server (http://bmerc-
www.bu.edu/psa/) was used for secondary structure predictions.
2.6. Puri¢cation of phasin from R. eutropha PHA granules and
recombinant E. coli
Three di¡erent procedures were utilized: (1) Phasin was puri¢ed for
amino-terminal sequencing and digestion analysis from PHA granules
harvested from R. eutropha cultures using Triton X-114 solubilization
[6]. This protein is hereafter referred to as X-114-phasin. Such samples
are not suitable for MALDI TOF MS due to the heteropolymeric
nature of the detergent. (2) Phasin was puri¢ed from granules for
MALDI TOF MS by boiling granules (approximately 50 mg wet
weight) in 10% (w/v) SDS. This protein is hereafter referred to as
SDS-phasin. The homogeneous nature of SDS allows these samples
to be used for mass spectrometry. Amino-terminal sequencing of the
initial six residues was used to con¢rm the identity of each phasin as
authentic. (3) Protein extracts were prepared from recombinant E. coli
by boiling cells for 10 min in SDS-PAGE loading bu¡er. This protein
is hereafter referred to as recombinant-phasin. Proteins were electro-
phoresed using discontinuous Tris-glycine SDS-PAGE (15% acryl-
amide) [11] with a Mini-PROTEAN II apparatus (Bio-Rad). Gels
were stained with Coomassie Brilliant Blue.
2.7. Protein and peptide sequencing
Protein sequencing was carried out using an ABI 477A pulsed
liquid protein microsequencer with 120A on-line analyzer. Granule
extract containing phasin was electrophoresed as previously reported
[11]. The protein was transferred to Problott membranes (Applied
Biosystems) using a Mini Trans Blot apparatus (BioRad) in accord-
ance with the manufacturer’s instructions. Cyanogen bromide cleav-
age was carried out as previously reported [12]. Hexadimethrine bro-
mide was used to prevent the loss of peptide fragments during
cyanogen bromide cleavage.
2.8. Mass spectrometry
Following SDS-PAGE the stained protein band was excised from
the gel and digested with trypsin [13]. Following overnight digestion,
0.5 Wl was sampled directly from the digest supernatant for MS anal-
ysis using a TofSpec 2E laser desorption time of £ight MS (Micro-
mass, UK). The remaining digested peptides (s 90% of total digest)
were extracted with washes of 5% (v/v) aqueous tri£uoroacetic acid
and acetonitrile, pooled and dried. Peptides were then derivatized with
N-succinimidyl-2-morpholine acetate to improve b-ion abundance and
facilitate sequence analysis by tandem mass spectrometry [14]. Dried
peptide fractions were treated with 7 Wl of freshly prepared, ice-cold
1% (w/v) N-succinimidyl-2-morpholine acetate in 1.0 M HEPES (pH
7.8 with NaOH) containing 2% (v/v) acetonitrile. After incubation for
20 min on ice the reaction was terminated by the addition of 1 Wl
hepta£uorobutyric acid and diluted with an equal volume of water.
The solution was then injected in 3U5 Wl aliquots onto a capillary
reverse-phase column (300 WmU15 cm) packed with POROS R2/H
material (Perceptive Biosystems, MA) equilibrated with 2% (v/v)
methanol/0.05% (v/v) tri£uoroacetic acid running at 3 Wl/min. The
adsorbed peptides were washed isocratically with 15% (v/v) metha-
nol/0.05% (v/v) tri£uoroacetic acid for 30 min at 3 Wl/min to elute
the excess reagent and HEPES bu¡er. Derivatized peptides were
eluted with a single step gradient to 75% (v/v) methanol/0.1% (v/v)
formic acid and collected in two 3 Wl fractions. Eleven derivatized
peptides, from 11^19 residues in length, were then fully sequenced
by low-energy collision-activated dissociation (CAD) using a Finnigan
MAT LCQ ion-trap MS ¢tted with a nanoelectrospray source [15,16].
CAD was typically performed with collisional o¡set voltages between
317 V and 335 V.
3. Results
3.1. PCR and DNA sequence analysis
Initial studies were aimed at the isolation of phasin cDNA
(727 bp) from the plasmid pVK5000 using the 5PGA24 and
3PGA24 oligomers. Sequencing of several clones found con-
sistent di¡erences from the Genbank database deposition
(Fig. 1). These di¡erences had e¡ects on the length of the
phasin protein and also the sequence of the carboxyl terminus,
which has strong signi¢cance for the model proposed for pha-
sin granule binding [6]. The same nucleotide di¡erences in
multiple clones from di¡erent PCR events using a high-¢delity
polymerase (Vent) indicated that polymerase ¢delity was not
responsible for the observed sequence. One possibility was
that mutations had arisen in the DNA either because the
phaP gene had not been subjected to selection pressure or
due to a reverse mistranscription. Accordingly, we ampli¢ed
and sequenced phasin genomic DNA from R. eutropha strains
H16 and H2275 which con¢rmed the results of PCR from the
pVK5000 plasmid.
The DNA sequence contained three di¡erences from the
published sequence (Genbank accession number X85729)
and the deduced amino acid sequence gave rise to a protein
of 192 amino acids and a calculated molecular mass of
19966.35 Da compared with previously reported values of
228 amino acids and 23978.04 Da. The sequence di¡erences
(see Fig. 1) were: (1) substitution of a cytidine residue for a
guanidine residue at position 369 of the ORF, with no e¡ect
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on the resulting amino acid residue; (2) omission of the gua-
nidine residue reported at position 496 of the ORF, resulting
in a shift of reading frame which alters the primary structure
of the protein from that point forward (Gly-166 becoming
Ala-166); and (3) exchange of the thymidine and adenine
residues reported at positions 632 and 633 of the ORF, which
falls outside of the new ORF due to the e¡ect of the frame-
shift.
3.2. Overexpression of phasin cDNA in E. coli and comparison
of wild-type and recombinant forms
Recombinant-phasin protein overexpressed from the pET-
GA24 vector in E. coli strain BL21(DE3) was compared by
SDS-PAGE with phasin from R. eutropha strain H16. The six
amino-terminal residues of recombinant-phasin were deter-
mined by amino-terminal sequencing as Met-Ile-Leu-Thr-
Phe-Glu, an exact match to the six amino-terminal residues
of R. eutropha phasin [6]. The heterologously expressed pro-
tein comigrated with X-114-phasin in numerous SDS-PAGE
experiments (example in Fig. 2). Recombinant-phasin protein
was produced from the transcription translation of pET-
GA24 vector DNA and was therefore as shown in Fig. 3
(not as previously published). No additional amino- or car-
boxyl-terminal residues were introduced via the cloning and
overexpression. Comigration of recombinant-phasin with
wild-type X-114-phasin from R. eutropha was further evidence
supporting the hypothesis that the sequence of the phasin
cDNA was an exact copy of the wild-type R. eutropha phaP
ORF.
R. eutropha phasin protein did not migrate according to the
predicted mass using standard protein molecular weight
markers; Fig. 2 shows recombinant-phasin and X-114-phasin
migrating equally at approximately 22 kDa compared to the
reference masses. The calculated size of the phasin protein
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Fig. 2. SDS-PAGE 15% acrylamide gel of phasin from heterologous expression and from R. eutropha PHA granules. Lane 1, protein size
standards (66, 45, 36, 29, 24, 20 and 14.2 kDa). Lane 2, recombinant-phasin pre-induction control. Lane 3, recombinant-phasin. Lane 4, re-
combinant-phasin mixed with X-114-phasin. Lane 5, X-114-phasin. Lane 6, protein size standards as above.
Fig. 1. Sequence of the phaP coding region with the di¡erences from the published sequence (Genbank accession number X85729) in underlined
boldface with boxes indicating the changes. The ORF (protein sequence shown in Fig. 3) is from 1^579 bp. Primers used in sequencing and
PCR (boxed) are described in Section 2.
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from the previously reported DNA sequence was 24 kDa
whereas the new DNA sequence would encode a protein of
mass 20 kDa. This anomalous electrophoretic mobility was
observed in preparations of phasin from PHA particles re-
gardless of which detergent (Triton X-114 or SDS) was used
in the phasin extraction process and was not therefore due to
the blocking of SDS-binding sites in Triton-treated samples.
Since the native and heterologous proteins migrated together
it was assumed that their masses, while indeterminate by this
method, were equivalent. Anomalous electrophoretic mobility
was not seen in published SDS-PAGE gels of the R. ruber
phasin [9,17] but is not uncommon (e.g. acyl carrier protein
from E. coli, which migrates at 18 kDa despite a mass of
9 kDa [18]). This can be due to hydrophobicity, conformation
or acidity of a protein.
3.3. Lack of a carboxyl-terminal peptide fragment in
X-114-phasin
Cyanogen bromide cleavage was performed on X-114-pha-
sin to determine whether a second methionine residue was
present within the primary structure (a clear di¡erence be-
tween the original and new sequences; see Fig. 1). No second-
ary peptide was observed in direct Edman degradation of the
sample after cleavage, a result consistent with the new protein
sequence. Hexadimethrine bromide was used to prevent the
loss of the expected small peptide (sequence Lys-Val-Val-Pro)
during the cleavage reaction. The lack of this cleavage frag-
ment could not con¢rm that a methionine residue does not
exist close to the carboxyl terminus of the protein but the
negative evidence was strongly suggestive.
3.4. Con¢rmation of protein sequence by MALDI TOF and
ion-trap MS
De¢nitive evidence of the sequence of the phasin protein
required the alignment of multiple digestion fragments with
the proposed sequence. The protein was digested with trypsin
and the resulting fragment masses determined by MALDI
TOF MS (Table 1 and Fig. 3). Of the 20 possible tryptic
fragments predicted from the sequence, 14 were matched by
mass measurement alone. The remaining six peptides were all
less than 500 Da and were not observed owing to interference
from low-mass ions associated with the alpha-cyano-4-hy-
droxycinnamic acid matrix. Mass errors between observed
and calculated masses were generally 6 0.1 Da. Masses cor-
responding to partial digest products were also observed for
peptides T3+T4 and T5+T6. Eleven peptides of masss 1000
Da were derivatized with succinimidyl-2-morpholine acetate
and sequenced by low-energy CAD using an ion-trap MS
¢tted with a nanoelectrospray source. Full sequences were
obtained for each peptide (Table 1 and Fig. 3). These masses
were in complete agreement with the newly deduced sequence,
with the restriction that low-energy collisional fragmentation
does not allow discrimination between leucine and isoleucine.
MS data obtained for peptide T16, showing complete b-ion
and y-ion coverage, is shown in Fig. 4. This sequence is of
signi¢cance as it covers the region where the previously re-
ported sequence diverges from that reported here.
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Fig. 3. Sequence and mass coverage for the deduced sequence of
phasin. The protein. Tryptic peptides matched by mass measurement
are underlined (H). Peptide sequences obtained following low-en-
ergy CAD are boxed. Peptide designations are in sequence order.
Table 1
Summary of MS data for tryptic peptides of phasin
Peptide Residues Calculated protonated mass
(Da)
Observed protonated mass
(Da)
vmass
(Da)
Sequence obtained
(low-energy CAD)
T1 1^13 1399.76 1399.72 30.04 M[LI][LI]TPEQVAAAQK
T2 14^25 1307.72 1307.69 30.03 AN[LI]ET[LI]FG[LI]TTK
T3 26^32 779.39 779.27 30.12 ^
T4 33^42 1154.71 1154.64 30.07 [LI]VE[LI]N[LI]QVVK
T5 43^53 1138.54 1138.46 30.08 TSFAEGVDNAK
T6 54^54 147.11 ^ ^ ^
T7 55^59 489.30 ^ ^ ^
T8 60^78 1965.07 1965.04 30.03 DAQE[LI][LI]A[LI]QAAAVQPVAEK
T9 79^84 724.39 724.27 30.12 ^
T10 85^99 1782.86 1782.83 30.03 H[LI]YE[LI]ASETQSEFTK
T11 100^110 1102.58 1102.47 30.11 VAEAQ[LI]AEGSK
T12 111^121 1198.68 1198.63 30.05 NVQA[LI]VEN[LI]AK
T13 122^135 1343.72 1343.64 30.08 NAPAGSESTVA[LI]VK
T14 136^150 1552.76 1552.73 30.03 SA[LI]SAANNAYESVQK
T15 151^153 319.20 ^ ^ ^
T16 154^172 1934.98 1935.01 +0.03 QAVE[LI]AETNFQAAATAATK
T17 173^182 974.50 974.47 30.03 ^
T18 183^187 491.28 ^ ^ ^
T19 188^188 147.11 ^ ^ ^
T20 189^192 363.19 ^ ^ ^
T3,4 26^42 1915.09 1915.12 +0.03 ^
T5,6 43^54 1266.63 1266.60 30.03 ^
Tryptic peptides were numbered in sequence order (T1^T20). Peptide protonated masses ([M+H]1) measured by MALDI TOF MS are shown in
column 4. Corresponding sequences were obtained by low-energy CAD following derivatization with N-succinimidyl-2-morpholine acetate. Leucine
and isoleucine [LI] cannot be distinguished as they are isomers. Masses were also observed for the partial tryptic fragments T3+T4 and T5+T6.
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4. Discussion
The model of phasin-PHA interaction described in the lit-
erature was deduced from a comparison between the deduced
amino acid sequences of the phasins from R. eutropha and R.
ruber. In the R. ruber phasin the PHA granule-binding regions
HD1 and HD2 consist of two stretches of ten and nine con-
secutive hydrophobic or amphiphilic residues uninterrupted
by hydrophilic residues near the carboxyl terminus. Deletion
of these proposed membrane-spanning domains prevented the
protein from adhering to PHA granules in heterologous ex-
pression studies [9]. The putative membrane-binding regions
of the R. eutropha phasin were identi¢ed by searching the
deduced amino acid sequence for similar regions of non-hy-
drophilicity based upon an assumption of structural similarity
between the two phasins. Our work shows that the R. eutro-
pha phasin does not contain the regions so identi¢ed and
therefore the model proposed cannot be correct. The possibil-
ities that the same stretch of DNA encodes the 24 kDa and
20 kDa phasins through a tRNA mutation (permitting the
frameshift) or that there are two genes, are unlikely due to
a single band observed on Western hybridizations previously
FEBS 21703 18-3-99
Fig. 4. CAD MS data for peptide T16. Observed masses for b- and y-type fragment ions are shown for peptide T16 (SMA derivative). The
doubly protonated ion at m/z 1095.0 was fragmented with a collision o¡set of 333 eV. Figures in parenthesis were not observed but could be
calculated from the mass of the intact peptide, giving complete assignment of all 19 residues. Residue 5 is given the designation Xle as Leu
and Ile cannot be distinguished.
Fig. 5. Secondary structure predictions for the new phasin sequence. A plot of hydropathy is shown (positive values represent regions of hydro-
phobicity) above data for the probability per residue of being part of a helix or loop. A schematic of the proposed arrangement of hydropho-
bic and hydrophilic regions in relation to the surface of the PHA granule is also shown.
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reported [6], since in both cases proteins of di¡erent sizes
would be produced and resolved with the electrophoresis con-
ditions used.
We have analyzed the sequence of the R. eutropha phasin
generated by our work and have determined that it contains
no consecutive runs of seven or more non-hydrophilic resi-
dues. The disparity in size between the R. eutropha and R.
ruber phasins (20 kDa and 14 kDa, respectively) and the
scores for identity (16.2%) and similarity (39.8%) between
the two suggest that these two phasins are not phylogeneti-
cally related. The granule-associated protein encoded by the
phaP gene (formerly designated ORF5 [19]) of Chromatium
vinosum (Genbank accession number A27012) also has no
signi¢cant homology to other phasin sequences. Two gran-
ule-bound proteins of small apparent molecular mass from
Acinetobacter RA3849 (Genbank accession number L37761;
termed ORF1) and Aeromonas caviae (Genbank accession
number D88825, termed ORF) have been studied by separate
groups [20,21] and are related (61% sequence similarity to
each other but no signi¢cant similarity to other available pha-
sin sequences). None of the above putative phasins contain
regions of purely hydrophobic or amphiphilic character as
seen in the Rhodococcus protein, and only the Aeromonas
and Acinetobacter sequences share any signi¢cant similarity.
The amino-terminal sequences of a number of putative pha-
sins from methylotrophic bacteria [22] also show little homol-
ogy to other phasins. This indicates that phasin proteins are
functionally but not phylogenetically related, unlike the anal-
ogous oleosins which share a common ancestor. Extrapolation
of structure-function relationships from one phasin to another
must therefore be undertaken with caution.
Public domain sequence databases were searched using the
complete sequence of the R. eutropha phasin protein (Fig. 3).
One interesting match was to Gas Vesicle Protein C from
Anabaena £os-aquae (accession number P09413) [23], which
contained several short protein motifs similar to those found
in the phasin sequence (e.g. the Gln-Glu-Leu-Leu-Ala motif
beginning at residue 62). A search of the databases using the
carboxy-terminal 25 amino acid residues (the novel sequence
of this phasin generated by this work) revealed homology with
the alanine-rich region of the mouse clathrin coat assembly
protein AP180 (Genbank accession number Q61548), which is
believed to interact with the cytoplasmic tails of membrane
proteins on vesicle surfaces during synaptogenesis [24]. This
region of the phasin protein may therefore possibly be in-
volved in protein-protein interactions with other granule-asso-
ciated proteins. It may be signi¢cant that both the A. £os-
aquae and mouse proteins are located at intracellular mem-
brane interfaces or boundaries, as are phasin proteins.
The Protein Structure Analysis Server (http://bmerc-
www.bu.edu/psa/) [25^27], which uses large data sets derived
from the Brookhaven protein database to assign probabilities
of amino acid structural roles, was used to analyse the R.
eutropha phasin protein sequence (Fig. 5). It is highly prob-
able that the phasin consists predominantly of alpha-helical
arrangements of residues. No region of the protein had a high
probability of forming part of a beta-sheet or a turn. When
these data were compared with calculations of hydrophobicity
(Fig. 5 also), several features emerged. The region from Val-75
to Ala-123 is predominantly hydrophilic and of probably hel-
ical arrangement. This region is the longest uninterrupted
stretch of both hydrophilicity and probably helicity; it may
represent the cytoplasmic face of the protein. It is £anked by
the two most hydrophobic regions of the protein; from Leu-
64 to Gln-73 (a probable helix), and from Pro-124 to Ala-141
(a possible non-ordered loop region). This central region is
preceded by the predominantly hydrophobic amino-terminal
part of the protein containing an inverted repeat motif Gln-
Val-Ala-Ala-Ala-GlnT(55)TGln-Ala-Ala-Ala-Val-Gln begin-
ning at residue 7 which is unique to the R. eutropha protein.
The carboxyl terminus of the R. eutropha phasin (following
Ala-141) is predominantly hydrophilic, with two short (6 9
residues) regions of amphipathicity. This is similar to the R.
ruber and C. vinosum phasins, both of which possess a large
predominantly hydrophilic and probably helical region
£anked by slightly more hydrophobic regions. Secondary
structure prediction using the R. ruber protein sequence sug-
gests that the HD1 granule-binding region has an extremely
low probability of being helical ; this hydrophobic disordered
region is similar to that seen in the R. eutropha structure
prediction (Pro-124 to Ala-141). The related Aeromonas and
Acinetobacter phasins are di¡erent, with hydrophilic residues
being concentrated away from the central third of the primary
sequence in each case, and the carboxyl-terminal hydrophilic
region showing extremely high probability of helicity. The
large hydrophilic domains may represent the cytoplasmic
faces of the phasins. Our schematic model shows the R. eu-
tropha phasin forming several potential granule-binding and
cytoplasm-oriented domains.
Recent studies of the PHA granule boundary show that the
interface may be as little as 4 nm in thickness, similar to that
seen at the surface of gas vesicles [3]. If the granule boundary
layer consists predominantly of protein, probably phasin, then
hydrophobic/amphiphilic membrane-spanning domains would
be super£uous and regions which bind directly to PHA will be
responsible for the anchoring of the proteins to the granule.
All known phasins have at least one markedly hydrophobic
region (e.g. Pro-124 to Ala-141 of the R. eutropha phasin).
Hydrophilic domains may form the cytoplasmic face of the
protein (as depicted in Fig. 5), or possibly interact with other
granule-bound proteins. Protein-protein interactions have not
been extensively studied; one or more domains of the phasin
may interact with the PHA synthase enzyme (which has been
reported to have higher turnover in the presence of phasin in
in vitro experiments [7]), the depolymerases or other uniden-
ti¢ed granule-associated proteins. Experiments to determine
the validity of our model using limited proteolysis of R. eu-
tropha phasin in conjunction with site-directed mutagenesis
experiments using recombinant phasin are currently under-
way.
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